PCB Logo

HBL PSL X to observe breast cancer awareness day; Fans encouraged to wear pink

Rawalpindi, 18 May 2025: The Rawalpindi Cricket Stadium will turn pink for the 30th fixture of the HBL PSL X between Islamabad United and Karachi Kings on Monday, 19 May.

As part of its corporate social responsibility, the HBL Pakistan Super League is supporting the Pink Ribbon campaign to create awareness about breast cancer. Earlier, the HBL PSL X observed Childhood Cancer Awareness Day on 3 May during the 23rd match of the tournament between Quetta Gladiators and Islamabad United at the Gaddafi Stadium in Lahore.

HBL PSL Chief Executive Officer Salman Naseer:

“The HBL PSL has always performed its duty of care by creating awareness about health-related issues and supporting noble causes. Breast cancer affects many lives, and it's essential to prioritize early detection and support those affected.

“Like we observed Childhood cancer awareness day, we are looking to perform our responsibility once again from the platform of HBL PSL, to create awareness about breast cancer. We urge our fans to support the cause by wearing pink when they come to the Rawalpindi Cricket Stadium.”

For the 19 May fixture, Islamabad United – the home side will wear specially designed pink-themed kits to mark the occasion. Karachi Kings and the match officials will wear pink caps in solidarity with the cause.

Additionally, players, match officials, coaching staff and commentators will wear pink ribbons throughout the match.

The stumps used for the Rawalpindi fixture will be branded pink. Breast cancer awareness messages will also be displayed on digital screens and LED perimeter boards at the venue to raise awareness and provide valuable information about the disease. Commentators will share awareness messages during the live commentary as well.

Additionally, in partnership with Holy Family Hospital, Benazir Bhutto Hospital, and Rawalpindi Teaching Hospital (DHQ), every ticket for Monday’s fixture will serve as a voucher for a free examination and screening of patients.